Is Non‐Sac Contained Matrix a Major Predictor for Residual Disease in Acquired Cholesteatoma?
Otolaryngology–Head and Neck Surgery · 2026
DOI: 10.1002/ohn.70080 ↗Kurz gefasst
Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2026. Verfasst von Friederike S Luetzenberg und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, University of Minnesota, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Cholesteatoma, Middle Ear. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
Objective
The objective of this study was to investigate predictive factors for residual disease in acquired cholesteatoma and determine whether the quality of the matrix having a continuous versus disrupted lining—sac versus nonsac contained—impacts the outcomes. Study Design Retrospective cohort study.
Setting
Academic teaching hospital.
Methods
Pediatric and adult EAONO‐JOS‐staged acquired cholesteatoma operated with endoscopic and combined approaches by the senior author from January 2015 to November 2023 were included. Presence of residual disease was determined through second‐look surgery, MRI with DWI, or by clinical examination following canal wall down mastoidectomy. Initial occurrence of residual disease was examined relative to age, sac versus non‐sac contained matrix, ossicular status, and surgical approaches using Cox proportional hazard models. Kaplan‐Meier curves were used to visualize time to disease stratified by predictive factors.
Results
Out of 105 ears included, 42% had residual disease. In isolation, non‐sac contained cholesteatoma (hazard ratio [HR] 3.89, 95% confidence interval [CI] 1.53‐9.89), pediatric patients (HR 1.97, 95% CI 1.01‐3.85), incus erosion (HR 2.43, 95% CI 1.17‐5.05), and stapes erosion (HR 2.01, 95% CI 1.02‐4.00) were significantly more likely to develop residual disease. EAONO/JOS stage and surgical approach were not significantly related. In multivariable modeling, only matrix quality retained significance, with non‐sac contained matrix associated with a threefold higher hazard of residual disease (HR 3.05, 95% CI 1.17‐7.93).
Conclusion
When accounting for several factors inherent to the disease process as well as surgical approach, a non‐sac contained cholesteatoma matrix was 3 times more likely to lead to residual disease in acquired cholesteatoma among all ages.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, University of Minnesota, Minneapolis, Minnesota, USA.
- University of Minnesota Medical School, Minneapolis, Minnesota, USA.
- HealthPartners Institute, HealthPartners, Bloomington, Minnesota, USA.
- Department of Otolaryngology-Head and Neck Surgery, Regions Hospital, HealthPartners, St. Paul, Minnesota, USA.
ORCID-Profile: Friederike S Luetzenberg, Manuela Fina
Zitieren
APA
Luetzenberg, F. S., Wald, J., Chrenka, E. A., & Fina, M. (2026). Is Non‐Sac Contained Matrix a Major Predictor for Residual Disease in Acquired Cholesteatoma?. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.70080
Vancouver
Luetzenberg FS, Wald J, Chrenka EA, Fina M. Is Non‐Sac Contained Matrix a Major Predictor for Residual Disease in Acquired Cholesteatoma?. Otolaryngology–Head and Neck Surgery. 2026. doi:10.1002/ohn.70080
BibTeX
@article{Luetzenberg2026,
author = {Luetzenberg, Friederike S and Wald, James and Chrenka, Ella A and Fina, Manuela},
title = {Is Non‐Sac Contained Matrix a Major Predictor for Residual Disease in Acquired Cholesteatoma?},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2026},
doi = {10.1002/ohn.70080}
}
EUVIMED